S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LCTX Lineage Cell Therapeutics Inc

0.5945

-0.0469 (-7.31%)

Last Updated: 10:49:15

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics Inc News

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 21 November 2024 (3 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 20 November 2024 (19 hours ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
Wednesday 20 November 2024 (1 day ago) • Business Wire

Form 8-K - Current report
Thursday 14 November 2024 (7 days ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Thursday 14 November 2024 (7 days ago) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
Thursday 7 November 2024 (2 weeks ago) • Business Wire

Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit
Monday 14 October 2024 (1 month ago) • Business Wire

OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
Wednesday 25 September 2024 (2 months ago) • Business Wire

Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
Wednesday 18 September 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Monday 19 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (3 months ago) • Edgar (US Regulatory)

More Lineage Cell Therapeutics Inc News Articles

Quantum Computing

Sincerity Applied Materi... (PK)

Apple Rush (PK)

Global Developments (PK)

Net Savings Link (PK)

Asia Broadband (PK)

Super Micro Computer

TheGlobe com (PK)

TPT Global Tech (PK)

Accredited Solutions (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions